BioTech 365

SEPTEMBER 2, 2020

NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, … Continue reading → SOUTH JORDAN, Utah, Sept.

Radiology 40

Radiology Cardiology Manufacturing Marketing 40

FDA Law Blog

OCTOBER 16, 2023

Can the FDA Keep them Safe”—focuses on FDA’s role in regulating clinical applications of AI/ML technologies and the impact of FDA’s regulatory requirements on the type of products developers choose to bring to market and how quickly they can be improved once there.

Radiology 119

Radiology Regulation Production Development 119

The Pharma Data

FEBRUARY 21, 2022

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

Radiology 52

Radiology Cardiology Development Production 52

XTalks

APRIL 19, 2024

Both tools represent Avicenna.AI’s focus on developing tools that integrate AI within the radiology workflow, improving the speed and accuracy of medical diagnostics. According to GlobalData , the global AI in healthcare market was valued at $81.3 AI in medical imaging is a large segment driving the market. percent and 24.2

Marketing 52

Marketing Radiology Development Manufacturing 52

The Pharma Data

OCTOBER 26, 2020

With this new joint venture, to be known as Arizona Diagnostic Radiology Group, RadNet has established an operating platform in the Phoenix metropolitan area, a rapidly growing market and home to almost five million people. RadNet’s core markets include California, Maryland, Delaware, New Jersey, New York, and now Arizona.

Radiology 40

Radiology Marketing Development Medicine 40

pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 111

Radiology Marketing Genome Genomics 111

Delveinsight

JANUARY 14, 2021

Other Hallux Valgus marketed devices includes Lapidus Plating System (LPSTM) , which is approved for the correction of mild to extreme forefoot H.V., Besides Treace, Wright Medical Technology is also a major contender in the Hallux Valgus market. Hallux Valgus market for years now. subsequent bunions and related instability.

Marketing 52

Marketing Radiology Production Development 52

Pharmaceutical Technology

NOVEMBER 30, 2022

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Vaccination 147

Vaccination Vaccine Development Gene Therapy 147

The Pharma Data

SEPTEMBER 30, 2021

Food and Drug Administration authorized marketing of software to help medical professionals who examine body tissues (pathologists) within the detection of areas that are suspicious for cancer as an adjunct (supplement) to the review of digitally-scanned slide images from prostate biopsies (tissue faraway from the body). Today, the U.S.

Radiology 52

Radiology In-Vitro Marketing Drugs 52

pharmaphorum

JANUARY 17, 2023

qXR has been trained on more than 2 million X-rays and their corresponding radiology reports, using deep-learning algorithms to interpret the images. have been working together since 2022, through the pharma group’s Emerging Markets Health Innovation Hubs programme. ” AZ and Qure.ai

Radiology 110

Radiology Pharma Companies Trials Marketing 110

pharmaphorum

APRIL 16, 2021

It’s been working closely with Microsoft since 2019, and its main products – including Dragon Ambient eXperience (DAX), Dragon Medical One and PowerScribe One for radiology reporting – are all built on Microsoft’s Azure cloud platform. History in the making!

Radiology 92

Radiology Doctors Doctor Production 92

pharmaphorum

OCTOBER 20, 2020

Demand for telehealth solutions like tele-ICU, tele-radiology, tele-pathology, to help virtual working of care professionals also drove growth in Q3. Frans van Houten also teased Philips’ financial 2021-2025 targets which will be released in full at its Capital Markets Day on 6 November.

Sales 105

Sales Radiology Medicine Production 105

Camargo

OCTOBER 8, 2020

While the sponsor initially planned to approach the Center for Radiological Health (CDRH), it soon became apparent that the combination product should be submitted to the Center for Drug Evaluation and Research (CDER). Camargo provided support by planning the key sections of the TPP to align sponsor goals, patient needs, and product labeling.

Production 130

Production Drugs Radiology Development 130

The Pharma Data

NOVEMBER 6, 2020

Food and Drug Administration (FDA) permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD). . SILVER SPRING, Md. ,

Marketing 40

Marketing Production Radiology Cosmetics 40

The Pharma Data

SEPTEMBER 16, 2020

The move is intended to increase flexibility for health labs to make tests available through the market. These claims were dismissed by HHS Chief of Staff Brian Harrison, who said that: “Every interaction between the secretary and commissioner has been highly professional.”. Matt Fellows. Source link.

Radiology 52

Radiology Marketing Development Medicine 52

XTalks

OCTOBER 26, 2022

The life cycle of a medical device encompasses several phases, initiating from the spark of a feasible idea of the device’s design, followed by an analysis of patients’ need for the plausible device, development and validation of medical device’s design, approval from the regulatory agency, a launch of the device and finally post-market research.

Production 98

Production Radiology Marketing Development 98

The Pharma Data

OCTOBER 19, 2020

Adventist Health is pleased to partner with RadNet, the nation’s leading outpatient radiology provider. RadNet’s core markets include California, Maryland, Delaware, New Jersey, New York, and now Arizona. RadNet, Inc. RadNet has a network of 332 owned and/or operated outpatient imaging centers.

Radiology 52

Radiology Production Marketing 52

XTalks

SEPTEMBER 9, 2022

George, MD, distinguished professor of Psychiatry, Radiology and Neuroscience, and director of the Brain Stimulation Division, Psychiatry at the Medical University of South Carolina, in Magnus Medical’s press release. SAINT is not the only neurostimulation system for depression to be recently cleared by the FDA.

Radiology 98

Radiology Life Science Licensing Licensing 98

FDA Law Blog

AUGUST 7, 2023

By Véronique Li, Senior Medical Device Regulation Expert — The Center for Devices and Radiological Health (CDRH) offers learning opportunities for new and experienced CDRH staff through the Experiential Learning Program (ELP). It was also helpful to hear first-hand the practical challenges companies navigate in bringing products to market.

Radiology 40

Radiology Production Regulation Manufacturing 40

The Pharma Data

OCTOBER 1, 2021

Currently, the quality dose for all marketed GBCAs, including gadobutrol and gadoterate, is 0.1 Dr. Olaf Weber, Head of Radiology Research and Development at Bayer. About Radiology at Bayer Everyone deserves clear answers about their health, starting with an early and accurate diagnosis. mmol/kg weight. “At

Radiology 52

Radiology Life Science Development Production 52

XTalks

MARCH 27, 2023

The primary endpoints were global cure (consisting of clinical cure, radiological cure and mycological eradication) at 14 days for the European Medical Agency (EMA), and a 30-day all-cause mortality for the US FDA. Rezafungin met the endpoints outlined by both the EMA and FDA.

Clinical Trials 98

Clinical Trials Clinical Trials Branding Trials 98

The Pharma Data

MARCH 24, 2021

In May 2020, AstraZeneca received support of more than $1bn from BARDA for the development, production and delivery of the vaccine under an agreement with the US Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. JPEO-CBRND.

Radiology 52

Radiology Vaccination Vaccine Trials 52

Drug Discovery World

OCTOBER 2, 2023

are all available currently. Judicious use of AI in clinical trials There is a plethora of AI tools available in the market – some of them are regulatorily approved, some are well validated and published upon, and some are at various stages of incomplete approval. European Journal of Radiology 105 (2018) 246–250 [4] Jiang, et al.

Clinical Trials 57

Clinical Trials Clinical Trials Trials Radiology 57

FDA Law Blog

JUNE 28, 2023

Baumhardt, Senior Medical Device Regulation Expert & Philip Won — The Center for Devices and Radiological Health’s (CDRH) Standards and Conformity Assessment Program (S-CAP) encourages medical device sponsors to use FDA-recognized voluntary consensus standards in their product submissions.

Containment 52

Containment Radiology Cosmetics Manufacturing 52

XTalks

APRIL 27, 2021

The US Food and Drug Administration (FDA) has authorized marketing of a new neurological rehabilitation device to assist in maintaining or increasing range of motion as part of muscle re-education in patients undergoing stroke rehabilitation. The device is approved for use in patients 18 years of age and older.

Radiology 105

Radiology Development FDA Approval Containment 105

Delveinsight

DECEMBER 29, 2020

Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their partnership deal to develop and market relugolix for prostate cancer and women’s health. . Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist.

Trials 52

Trials Drugs Hormones Radiology 52

XTalks

APRIL 7, 2021

The new, revised EUA will allow the company to market the test for the qualitative detection of SARS-CoV-2 from nasal swab samples for screening use with serial testing. The EUA allows for the marketing of the device in the US.

Antibody 102

Antibody Immune Response Radiology Marketing 102

The Pharma Data

DECEMBER 14, 2020

Program grants are awarded to companies with promising technologies that have a strong potential for commercialization, to help translate life-saving innovations to consumer markets and create jobs in biotechnology. About Alume Biosciences, Inc. ————-. This award was granted by the National Institutes of Health.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Radiology 52

The Pharma Data

MARCH 22, 2021

In May 2020, AstraZeneca received support of more than $1bn from BARDA for the development, production and delivery of the vaccine under an agreement with the US Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. JPEO-CBRND.

Trials 52

Trials Vaccination Vaccine Radiology 52

pharmaphorum

SEPTEMBER 30, 2022

Assuming the FDA decides that the efficacy and safety data for lecanemab is strong, it could opt to approve the drug via the accelerated approval mechanism – with a decision on that due by 6 January – or wait to review the full marketing application, including the Clarity AD results that will be submitted in the first quarter of next year.

Clinical Trials 52

Clinical Trials Clinical Trials Sales Drugs 52

The Pharma Data

NOVEMBER 28, 2020

TeraRecon’s end-to-end AI ecosystem, including the Eureka AI Results Explorer, AI interoperability platform, and Intuition advanced visualization technologies will be exhibited during the upcoming Radiological Society of North America’s 2020 Annual Scientific Virtual Session from Sunday, November 29 th – Saturday, December 5 th.

Radiology 52

Radiology Marketing Production Development 52

FDA Law Blog

NOVEMBER 17, 2022

Koblitz — As was introduced in our recent blog post summarizing the 2022 MedTech conference ( here ), FDA’s Center for Devices and Radiological Health (CDRH) recently announced the launch of a new pilot program, the Voluntary Total Product Life Cycle (TPLC) Advisory Program (TAP) Pilot ( see announcement attributed to CDRH director Jeff Shuren, M.D.,

Regulation 69

Regulation Production Radiology Development 69

XTalks

FEBRUARY 10, 2021

The US Food and Drug Administration (FDA) has granted marketing authorization to Signifier Medical Technologies ’ sleep apnea treatment device, called eXciteOSA. The new device is designed to reduce snoring and treat mild obstructive sleep apnea (OSA) in individuals 18 years and older, and is available by prescription only. How it Works.

Radiology 97

Radiology Marketing Clinical Trials Clinical Trials 97

FDA Law Blog

NOVEMBER 21, 2022

The TAP Pilot is intended to “de-risk the medical device valley of death,” the metaphorical place where innovative technologies die while trying to reach the market. here ), Federal Register notice ( here ) and the Program Website ( here )). here ), Federal Register notice ( here ) and the Program Website ( here )). Food & Drug Admin.,

Regulation 59

Regulation Production Radiology Development 59

Delveinsight

SEPTEMBER 2, 2021

This designation was based on positive clinical data from the first 21 Impella ECP patients treated as part of an FDA-regulated early feasibility study and will give priority during the Impella ECP’s regulatory review processes comprising of design iterations, clinical study protocols, and pre-market approval (PMA) application.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72

The Pharma Data

MARCH 29, 2022

AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorisation in the European Union (EU) for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg.

Antibody 52

Antibody In-Vivo Vaccination Vaccine 52

The Pharma Data

MARCH 25, 2022

AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been recommended for marketing authorisation in the European Union (EU) for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg.

Antibody 52

Antibody In-Vivo Medicine Vaccination 52